Xstrahl Limited

+44 (0) 1276 462 696http://www.xstrahl.com

Request Information

Xstrahl to launch advanced software development simultaneously at AACR and ESTRO

The American Association for Cancer Research (AACR) and the European Society for Radiotherapy & Oncology (ESTRO) will provide the ideal platform for Xstrahl to publically launch Muriplan, the new Pre-Clinical Treatment Planning System for the Xstrahl Small Animal Radiation Research Platform (SARRP).

Muriplan is built on the same platform as the existing SARRP Treatment/Dose Planning System. Since the original TPS release in April 2012, Xstrahl has been listening to customer feedback. The user requirement to have contouring and advanced image registration tools to better delineate the tumour volume has been added into Muriplan. Along with advanced evaluations tools such as DVH and Isodose lines. Muriplan represents the very latest innovation in Small Animal Image Guided Irradiation planning.

Muriplan’ imaging module permits users to create a CBCT and a reconstruction protocol on the fly, allowing for pre and post filtering as well as a variable voxel size.  Registration algorithms are available to fuse DICOM images to allow functional imaging or better soft tissue imaging. Muriplan’s contouring module gives the user access to multiple tools from a brush to an IntelliMap tool to create contours for organs at risk and tumour volumes.  Using this data researchers can create a plan with beams or arcs that mimic clinical geometry. 

The CT reconstruction and dose calculation algorithms run on the fast Tesla (GPU) thus dramatically decreasing the amount of time spent with the specimen under anaesthesia.  To determine plan quality and accuracy, MuriPlan offers a view with Isodose lines over the contours.  The user can evaluate the volumes in a Dose Volume Histogram.  Previous plans can be overlaid to evaluate changes in tumour for Adaptive Planning. Plans can be easily exported to the SARRP software for delivery.  Each plan parameters can be saved for other mice, consequent treatments or as a text file to report the irradiation from a specific subject.

Using Clinical forethought, MuriPlan represents a clinical treatment in a pre-clinical setting. Xstrahl is continuing it’s committed to introduce innovative product solutions to the radiotherapy market.

Along with the launch of Muriplan, ESTRO (Vienna Congress Center, 5th – 9th April, Vienna, Austria) will play host to the 2014 European SARRP Symposium. Following on from the success of the SARRP User Group meeting at ASTRO2013, the symposium will look at the role SARRP plays across the ESTRO2014 scientific programme. Open discussion will be encouraged, while talks and presentations from Small Animal Micro-Irradiation field experts (with backgrounds in Physics, Radiation Oncology and Biology) will take place. The European Symposium will also host the European launch of Muriplan. The event will be on the 7th April from 6pm to 8pm at the ESTRO Meeting Room 3, Reed Messe Vienna Congress Center. Please register your interest with Smaragda Progiou at SmaragdaProgiou(dot)Xstrahl(dot)com or click here for more information.

Xstrahl Medical will also be showcasing its comprehensive range of superficial and orthovoltage X-Ray therapy systems (Xstrahl 100, 150, 200 and 300). Xstrahl is the leading designer and manufacturer of low-dose X–Ray medical solutions, providing nonsurgical alternatives for patients with superficial skin disorders, and benign conditions.

In America, AACR (San Diego Convention Center, 5th – 9th April, San Diego, California) will see Xstrahl Life Sciences displaay their range of radiation based scientific research solutions. The Xstrahl booth will allow attendees to witness how cancer research is being enhanced by Xstrahl's SARRP Image Guided Micro-Irradiator (IGMI™). SARRP is enhancing understanding of how radiation interacts with tissue, the mechanisms of DNA repair and ultimately how radiation can be used in the most effective way to improve patient centred healthcare.

Xstrahl look forward to meeting all collaborators, scientists and clinicians at both ESTRO and AACR.